Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4529004
Max Phase: Preclinical
Molecular Formula: C19H15N3O4S
Molecular Weight: 381.41
Molecule Type: Unknown
Associated Items:
ID: ALA4529004
Max Phase: Preclinical
Molecular Formula: C19H15N3O4S
Molecular Weight: 381.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=[N+]([O-])c1cccc(S(=O)(=O)NN=C(c2ccccc2)c2ccccc2)c1
Standard InChI: InChI=1S/C19H15N3O4S/c23-22(24)17-12-7-13-18(14-17)27(25,26)21-20-19(15-8-3-1-4-9-15)16-10-5-2-6-11-16/h1-14,21H
Standard InChI Key: XXLGAXCKPIMKKK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 381.41 | Molecular Weight (Monoisotopic): 381.0783 | AlogP: 3.33 | #Rotatable Bonds: 6 |
Polar Surface Area: 101.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.86 | CX Basic pKa: | CX LogP: 4.41 | CX LogD: 4.40 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.40 | Np Likeness Score: -1.37 |
1. Arshia, Begum F, Almandil NB, Lodhi MA, Khan KM, Hameed A, Perveen S.. (2019) Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico., 27 (6): [PMID:30738655] [10.1016/j.bmc.2019.01.043] |
Source(1):